168 related articles for article (PubMed ID: 23440347)
1. Type-specific prevalence of human papillomavirus in women screened for cervical cancer in Labrador, Canada.
Severini A; Jiang Y; Brassard P; Morrison H; Demers AA; Oguntuase E; Al-Rushdi M; Preston F; Ratnam S; Mao Y
Int J Circumpolar Health; 2013; 72():. PubMed ID: 23440347
[TBL] [Abstract][Full Text] [Related]
2. Distribution of human papillomavirus types, cervical cancer screening history, and risk factors for infection in Manitoba.
Demers AA; Shearer B; Severini A; Lotocki R; Kliewer EV; Stopera S; Wong T; Jayaraman G
Chronic Dis Inj Can; 2012 Sep; 32(4):177-85. PubMed ID: 23046799
[TBL] [Abstract][Full Text] [Related]
3. Type-specific prevalence of Human Papillomavirus infection among women in the Northwest Territories, Canada.
Jiang Y; Brassard P; Severini A; Goleski V; Santos M; Leamon A; Chatwood S; Lys C; Johnson G; Wong T; Kotaska A; Kandola K; Mao Y
J Infect Public Health; 2011 Nov; 4(5-6):219-27. PubMed ID: 22118716
[TBL] [Abstract][Full Text] [Related]
4. [Study on the genotyping of human papillomavirus using a new DNA liquid chip in women of high-risk group of Shandong province].
Liu M; Wang CX; Deng XM; Wang LS; Zhang J; Li W; Zheng GX; Wang JF
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 May; 28(5):487-90. PubMed ID: 17877181
[TBL] [Abstract][Full Text] [Related]
5. Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.
Aoyama-Kikawa S; Fujita H; Hanley SJB; Kasamo M; Kikuchi K; Torigoe T; Matsuno Y; Tamakoshi A; Sasaki T; Matsuura M; Kato Y; Dong P; Watari H; Saito T; Sengoku K; Sakuragi N
Cancer Sci; 2018 Jun; 109(6):2003-2012. PubMed ID: 29660849
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study).
Orlando G; Tanzi E; Chatenoud L; Gramegna M; Rizzardini G;
BMC Cancer; 2012 May; 12():204. PubMed ID: 22646512
[TBL] [Abstract][Full Text] [Related]
7. Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand.
Simonella LM; Lewis H; Smith M; Neal H; Bromhead C; Canfell K
BMC Infect Dis; 2013 Mar; 13():114. PubMed ID: 23452957
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus genotypes distribution by cervical cytologic status among women attending the General Hospital of Loandjili, Pointe-Noire, Southwest Congo (Brazzaville).
Boumba LM; Qmichou Z; Mouallif M; Attaleb M; El Mzibri M; Hilali L; Donatien M; Ennaji MM
J Med Virol; 2015 Oct; 87(10):1769-76. PubMed ID: 25963674
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus prevalence and type-distribution among women in Zhejiang Province, Southeast China: a cross-sectional study.
Liu XX; Fan XL; Yu YP; Ji L; Yan J; Sun AH
BMC Infect Dis; 2014 Dec; 14():708. PubMed ID: 25523884
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of human papillomavirus and its impact on cervical dysplasia in Northern Canada.
Jiang Y; Brassard P; Severini A; Mao Y; Li YA; Laroche J; Chatwood S; Corriveau A; Kandola K; Hanley B; Sobol I; Ar-Rushdi M; Johnson G; Lo J; Ratnam S; Wong T; Demers A; Jayaraman G; Totten S; Morrison H
Infect Agent Cancer; 2013 Jul; 8(1):25. PubMed ID: 23816397
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus infection and the association with abnormal Pap findings in Yukon, Canada.
Jiang Y; Hanley B; Brassard P; Severini A; Lo J; O'Donovan S; Duncan L; Luo ZC; Tohme S; Mao Y; Morrison H
J Low Genit Tract Dis; 2013 Jul; 17(3):346-53. PubMed ID: 23733163
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of high-risk human papilloma virus in liquid-based cervical samples from Turkish women with normal and abnormal cytology.
Seneldir H; Kir G
Diagn Cytopathol; 2019 Feb; 47(2):100-104. PubMed ID: 30457213
[TBL] [Abstract][Full Text] [Related]
13. Genotype distribution and prevalence of human papillomavirus among women with cervical cytological abnormalities in Xinjiang, China.
Wang J; Tang D; Wang J; Zhang Z; Chen Y; Wang K; Zhang X; Ma C
Hum Vaccin Immunother; 2019; 15(7-8):1889-1896. PubMed ID: 30735478
[No Abstract] [Full Text] [Related]
14. [Performance of combined liquid based cytology and HPV nucleic acid test for detecting cervical precancer among women attending screening].
Jiang MY; Feng RM; Wang L; Li TY; Zhang AA; Cui JF; Pan QJ; Zhang X; Liu ML; Gao F; Chen W; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):750-756. PubMed ID: 30392339
[No Abstract] [Full Text] [Related]
15. Meta-analysis of type-specific human papillomavirus prevalence in Iranian women with normal cytology, precancerous cervical lesions and invasive cervical cancer: Implications for screening and vaccination.
Jalilvand S; Shoja Z; Nourijelyani K; Tohidi HR; Hamkar R
J Med Virol; 2015 Feb; 87(2):287-95. PubMed ID: 25156655
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of high-risk HPV types and abnormal cervical cytology in American Indian/Alaska Native women, 2003-2005.
Alfonsi GA; Datta SD; Mickiewicz T; Koutsky LA; Ghanem K; Hagensee M; Kerndt P; Hsu K; Weinstock H; Shlay JC
Public Health Rep; 2011; 126(3):330-7. PubMed ID: 21553660
[TBL] [Abstract][Full Text] [Related]
17. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
18. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
[TBL] [Abstract][Full Text] [Related]
19. [Human Papilloma Virus (HPV), cervical cancer incidence and screening uptake: differences among Northern, Central and Southern Italy].
Giorgi Rossi P; Chini F; Borgia P; Guasticchi G; Carozzi FM; Confortini M; Angeloni C; Buzzoni C; Buonaguro FM;
Epidemiol Prev; 2012; 36(2):108-19. PubMed ID: 22706361
[TBL] [Abstract][Full Text] [Related]
20. [Association between high risk human papillomavirus DNA load and cervical lesions in different infection status].
Li TY; Wu ZN; Jiang MY; Cui JF; Liu B; Chen F; Chen W
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):475-480. PubMed ID: 29936777
[No Abstract] [Full Text] [Related]
[Next] [New Search]
